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Cases of massive purulent infection of vascular prosthesis are demonstrated in
this study. Infected prosthesis was substituted by arterial homograft, harvested
during multi-organ procurement, and stored by the cold ischaemia method. In
the follow-up period, the patients were divided into two groups, those treated
with immunosuppression (n = 16) and those treated without immunosuppres-
sive drugs (n = 13). The patients underwent resurgery, during which a fragment
of arterial wall was taken for electron microscopic examination.
In the group with immunosuppression, the presence of the following structures
was observed: endothelial cells, the intima, with a great number of elastic and
collagen fibrils with fibrinogen inclusions, and active phagocyting myoblasts and
myofibroblasts. In the group without immunosuppression electron microscopic
examination showed the total destruction of the wall of the ruptured arterial
homograft — absence of endothelium and sparse, damaged fibroblasts of the
media or their degraded fragments, making a picture of cellular death.
Morphological analysis of the arterial wall and the clinical state of the patient
suggest the necessity of immunosuppressive treatment after fresh arterial ho-
mograft transplantation.
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veins collected from a graft donor [1, 2, 4, 6–9]. The
application of tissue material in place of synthetic
substance makes the process of inflammatory focus
healing easier [1, 2, 4, 6–9]. The problem still re-
mains, however, of the viability of the graft in terms
of its antigenicity, as well as the use of immunosup-
pression associated with this [3, 7, 8].
MATERIAL AND METHODS
In the years 2000–2002 29 patients with infec-
tion of the whole arterial prosthesis in the aortic-
iliac-femoral segment underwent surgery. Fresh ar-
INTRODUCTION
The common application of vascular prostheses has
caused an increase in the number of patients operated
on and thus an increase in the number of infections
associated with the use of artificial materials, as well
as complications following infection [1, 8, 10].
The unsatisfactory results of the treatment when
the classical approach to infection control is em-
ployed have given rise to clinical trials aimed at tis-
sue graft application [1, 2, 4, 6, 8, 9]. For vessel re-
construction both a patient’s arteries and veins are
used, as well as homological material — arteries or
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terial allografts taken from graft donors were used.
Homografts were stored by the cold ischaemia meth-
od at +4°C, in preserving liquid UW (University of
Wisconsin) with antibiotics (lincomycin, vancomycin).
Diagnosis was confirmed by clinical examination,
laboratory investigations, bacteriological culture and
imaging studies (USG Duplex-Doppler, computed
tomography, scintigraphy with Technetium 99m la-
belled leukocytes). These studies were also applied
in postoperative examination. During qualification
of the patients for transplantation, blood grouping
was conducted, and in the case of fresh arterial
grafts, cross-matching tests were performed be-
tween the recipient serum and full suspension of lym-
phocytes and B cells from the recipient. Additional-
ly, antigens of HLA histocompatibility system class I
and II were determined, both of the recipient and
the donor. 29 patients were divided into two groups.
In 16 patients (group I) cyclosporin A was adminis-
tered after tissue graft implantation at doses
1–2 mg/kg/24 hours, paralleled with the drug level
measurements in serum. In 13 patients (group II) im-
munosuppression was not applied. In the last phase
of the follow-up, both the patients with and with-
out immunosuppression underwent surgery. Thus,
during reoperation, material was obtained for elec-
tron microscopic studies. The follow-up examinations
were complemented by studies of the vessel wall in
a patient who had stopped taking immunosuppres-
sive drugs.
RESULTS AND DISCUSSION
The patient profiles and the outcome of the op-
erative treatment are collected in Table 1. Both lab-
oratory and imaging studies confirmed regression
of infection in all the patients. In both groups of
patients operated on, specimens from transplanted
arterial allografts were taken during resurgery
— 9 months after transplantation without immuno-
suppression, and 12 months in the case of cyclospor-
in application. In a patient without immunosuppres-
sion a specimen was taken from the removed, rup-
tured iliac-femoral homograft. A patient treated with
immunosuppression was operated on due to arteri-
al embolism. During the surgery an edge of the in-
cised branch of the homograft was taken. Electron
microscopic examination showed total destruction
of the wall of the fractured arterial homograft
—absence of endothelium, sparse, damaged cells (fi-
broblasts) of the media, or their degraded fragments,
forming a picture of cellular death. In the artery col-
lected from a patient to whom immunosuppression
had been applied and who was operated on due to
acute limb ischaemia caused by arterial embolism,
a different picture was observed made up of the fol-
lowing features: the presence of cells of mechani-
cally-detached endothelium, thickened elastic lami-
na of the intima, the intima with a great number of
elastic and collagen fibrils with fibrinogen inclusions,
and active phagocyting myoblasts and myofibro-
blasts (Fig. 1). The activity of myofibroblasts of the
transplanted vessel wall was evident in the electron
microscopic pictures in the production of a high
quantity of collagen fibrils. Fibrinogen inclusions are
caused by its penetration from the arterial graft lu-
men. This patient stopped taking immunosuppres-
sive drugs and 12 months later underwent surgery
due to ischaemia of the left lower limb during throm-
bosis of the left branch of a bifurcated arterial ho-
mograft. A specimen from the homograft wall was
taken intraoperatively. An examination with an elec-
tron microscope showed the absence of vascular
Table 1. The comparison of patients after arterial transplant
Characteristic Group I Group II Statistic
Number 16 13 NS
Age 56 (42–68) 61 (50–71) NS
Men 15 11 NS
Women 1 2 NS
Homograft Y 11 (69%) 9 (69%) NS
By-pass 5 (31%) 4 (31%) NS
Vascular 2 (12,5%) 8 (61.5%) p = 0.0057
complications
Death after vas- – 2 (15%) NS
cular complications
Death – 4 (31%) NS Figure 1. Arterial wall with Cyclosporin. Endothelium.
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endothelium cells and a picture of cellular apoptosis
in the vessel wall (Fig. 2).
The main purpose of preparation of the arteries
for transplantation was the maintenance of vascu-
lar endothelium [7–9]. This was possible, thanks to
the storage of homograft in UW liquid at a temper-
ature of +4 degrees Celsius and delicate prepara-
tion of the arteries from the surrounding tissues
[1, 2, 7–9]. Electron microscopic study confirmed the
presence of endothelium in an arterial homograft
prepared for transplantation in such a way [7]. The
choice of this type of homograft storage was caused
by the reduced viability of the graft wall, as is docu-
mented in the literature, and retrograde changes to
the epithelium on the application of deep freezing
to the arterial homograft or allograft denaturation
[5, 7, 8]. Destruction of the wall of such an arterial
graft is especially evident on distant observation
[2, 6–8]. However, when fresh arterial grafts with
the preserved vascular endothelium are employed,
different problems arise. These are associated with
the use of immunosuppression in spite of infection,
as well as the necessity for donors and recipients to
be fully matched with respect to the compatibility
of the main blood groups in the ABO and HLA sys-
tems [2, 7, 8]. Compatibility in the ABO system and
negative cross-matching tests allow for the exchange
of infected prosthesis into the allograft [2, 7–9]. Im-
munosuppression enables the process of degrada-
tion of the arterial graft wall to be stopped and its
function sustained, which was possible due to the
preservation of the arterial endothelium [2, 7, 8].
Figure 2. Arterial wall without immunosuppression. Apoptosis of
cells.
This observation was confirmed in the studies ex-
amining the wall of arterial graft with an electron
microscope [7]. The absence of endothelium in ho-
mografts stored in a deep-frozen state accounts for
the complications associated with the degradation
of the graft wall [3–9].
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